Authors:
WILLIAMS KL
WINGER G
PAKARINEN ED
WOODS JH
Citation: Kl. Williams et al., NALTREXONE REDUCES ETHANOL-REINFORCED AND SUCROSE-REINFORCED RESPONDING IN RHESUS-MONKEYS, Psychopharmacology, 139(1-2), 1998, pp. 53-61
Authors:
METS B
WINGER G
CABRERA C
SEO S
JAMDAR S
YANG G
ZHAO K
BRISCOE RJ
ALMONTE R
WOODS JH
LANDRY DW
Citation: B. Mets et al., A CATALYTIC ANTIBODY AGAINST COCAINE PREVENTS COCAINE REINFORCING ANDTOXIC EFFECTS IN RATS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(17), 1998, pp. 10176-10181
Citation: Jm. Aspen et G. Winger, ETHANOL EFFECTS ON SELF-ADMINISTRATION OF ALFENTANIL, COCAINE, AND NOMIFENSINE IN RHESUS-MONKEYS, Psychopharmacology, 130(3), 1997, pp. 222-227
Citation: G. Winger et Jh. Woods, EFFECTS OF BUPRENORPHINE ON BEHAVIOR MAINTAINED BY HEROIN AND ALFENTANIL IN RHESUS-MONKEYS, Behavioural pharmacology, 7(2), 1996, pp. 155-159
Authors:
ACTEO MD
BOWMAN E
BUTELMAN E
ENGLISH JA
HARRIS L
JACOBSON AE
MATTSON MV
MEDZIHRADSKY F
PATRICK G
ROWLETT JK
SMITH CB
WINGER G
WOODS JH
WOOLVERTON WL
Citation: Md. Acteo et al., ZIPEPROL - PRECLINICAL ASSESSMENT OF ABUSE POTENTIAL, Drug and alcohol dependence, 42(2), 1996, pp. 93-104
Citation: G. Winger, REINFORCING EFFECTS OF INTRAVENOUSLY DELIVERED NMDA CHANNEL BLOCKERS IN RHESUS-MONKEYS - COMPARISON OF REINFORCING STRENGTH, Behavioural pharmacology, 6(5-6), 1995, pp. 636-636
Citation: Sr. Hursh et G. Winger, NORMALIZED DEMAND FOR DRUGS AND OTHER REINFORCERS, Journal of the experimental analysis of behavior, 64(3), 1995, pp. 373-384
Citation: Er. Butelman et al., BUTORPHANOL - CHARACTERIZATION OF AGONIST AND ANTAGONIST EFFECTS IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 845-853
Citation: G. Winger, DOPAMINE ANTAGONIST EFFECTS ON BEHAVIOR MAINTAINED BY COCAINE AND ALFENTANIL IN RHESUS-MONKEYS, Behavioural pharmacology, 5(2), 1994, pp. 141-152
Authors:
NEGUS SS
BUTELMAN ER
CHANG KJ
DECOSTA B
WINGER G
WOODS JH
Citation: Ss. Negus et al., BEHAVIORAL-EFFECTS OF THE SYSTEMICALLY ACTIVE DELTA-OPIOID AGONIST BW373U86 IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1025-1034